- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03235089
A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses
September 21, 2020 updated by: CooperVision, Inc.
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).
Study Overview
Detailed Description
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).
The primary outcomes of interest are lens fit and lens fit preference.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 18 years of age and has full legal capacity to volunteer
- Has read, fully understood and signed the information consent letter
- Currently wears or has previously worn soft contact lenses
- Has spectacle cylinder ≤1.00D in both eyes.
- Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
- Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
- Has clear corneas and no active ocular disease
- Is willing and able to follow product usage instructions and maintain the visit schedule.
Exclusion Criteria:
- Has never worn contact lenses before
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
- Has any known active ocular disease and/or infection
- Has a monovision correction
- Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses
- Is aphakic
- Has undergone corneal refractive surgery
- Is pregnant or lactating, determined by self-report
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Test lens
Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).
|
Daily disposable contact lens
Focus Dailies All Day Comfort contact lens (nelfilcon A)
|
|
ACTIVE_COMPARATOR: nelfilcon A lens (control)
Each subjects will wear a test lens in one eye and the control lens in the other as an unmatched pair, per predetermined randomization schedule (to determine which eye receives test/control lens).
|
Daily disposable contact lens
Focus Dailies All Day Comfort contact lens (nelfilcon A)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Horizontal Lens Centration Assessed in Primary Gaze
Time Frame: Baseline
|
Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps.
(mm-nasal decentration given +ve value, temporal decentration given -ve value)
|
Baseline
|
|
Horizontal Lens Centration Assessed in Primary Gaze
Time Frame: 6-hour
|
Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps.
(mm-nasal decentration given +ve value, temporal decentration given -ve value)
|
6-hour
|
|
Vertical Lens Centration Assessed in Primary Gaze
Time Frame: Baseline
|
Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps.
(mm-superior decentration given +ve value, inferior decentration given -ve value)
|
Baseline
|
|
Vertical Lens Centration Assessed in Primary Gaze
Time Frame: 6-hours
|
Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps.
(mm-superior decentration given +ve value, inferior decentration given -ve value)
|
6-hours
|
|
Lens Tightness Assessed by Push-up Test
Time Frame: Baseline
|
Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)
|
Baseline
|
|
Lens Tightness Assessed by Push-up Test
Time Frame: 6-hours
|
Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement)
|
6-hours
|
|
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
|
Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)
|
Baseline
|
|
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
|
Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps)
|
6 hours
|
|
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
|
Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)
|
Baseline
|
|
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
|
Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps)
|
6 hours
|
|
Overall Lens Fit Acceptance
Time Frame: Baseline
|
Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)
|
Baseline
|
|
Overall Lens Fit Acceptance
Time Frame: 6 hours
|
Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum)
|
6 hours
|
|
Up Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: Baseline
|
Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).
|
Baseline
|
|
Up Gaze Lag Assessed Observing Lens Movement in Graticule
Time Frame: 6 hours
|
Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze).
|
6 hours
|
|
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
Time Frame: Baseline
|
Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink
|
Baseline
|
|
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
Time Frame: 6 hours
|
Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink
|
6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 25, 2017
Primary Completion (ACTUAL)
August 3, 2017
Study Completion (ACTUAL)
August 3, 2017
Study Registration Dates
First Submitted
July 27, 2017
First Submitted That Met QC Criteria
July 27, 2017
First Posted (ACTUAL)
August 1, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 14, 2020
Last Update Submitted That Met QC Criteria
September 21, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-17-46
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Test Lens
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.CompletedMyopiaUnited States
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
CooperVision, Inc.CORECompleted